Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

158 results about "Structural analog" patented technology

A structural analog, also known as a chemical analog or simply an analog, is a compound having a structure similar to that of another compound, but differing from it in respect to a certain component.

Compound for inhibiting HBV transcription and hepatitis B surface antigen and application thereof

The invention belongs to the technical field of medical chemistry, and discloses a compound for inhibiting HBV transcription and hepatitis B surface antigen and application thereof. According to the invention, a small molecule compound for inhibiting HBsAg is screened from 5088 compounds by using a cell model, and a compound with a better effect is screened by screening structural analogues of the compound; the antiviral effects of the compounds are evaluated in different cell models, the compounds capable of remarkably inhibiting HBsAg are found, and the compounds 1-4 are novel potential antiviral drugs capable of inhibiting HBsAg by inhibiting HBV transcription and are expected to become novel anti-hepatitis B virus drugs.
Owner:CHONGQING MEDICAL UNIVERSITY

Corynebacterium glutamicum for producing L-isoleucine and application of corynebacterium glutamicum

The invention discloses corynebacterium glutamicum for producing L-isoleucine and application of the corynebacterium glutamicum. The strain is obtained by performing ultraviolet mutagenesis and structural analogue resistance screening on corynebacterium glutamicum ATCC13869. According to the method, the L-isoleucine can be produced through direct fermentation of glucose, the yield of the L-isoleucine can reach 51.69 g / L, the conversion rate can reach 28.5%, the production efficiency is improved, meanwhile, the main raw material glucose used for fermentation is low in price and easy to obtain, the method conforms to the green food safety production concept, and industrial production of the L-isoleucine is facilitated.
Owner:ANHUI HUAHENG BIOTECH CO LTD +2

Aptamer OUC-Fx11-5T of fucoxanthin and application thereof

The invention discloses a nucleic acid aptamer OUC-Fx11-5T of fucoxanthin and application of the nucleic acid aptamer OUC-Fx11-5T, and belongs to the technical field of nucleic acid aptamers. The nucleic acid aptamer OUC-Fx11-5T of the fucoxanthine has a nucleotide sequence as shown in SEQ ID NO. 19. The nucleic acid aptamer OUC-Fx11-5T of the fucoxanthine has a nucleotide sequence as shown in SEQ The invention further discloses the application of the nucleic acid aptamer OUC-Fx11-5T of the fucoxanthin in identification or detection of the fucoxanthin. According to the nucleic acid aptamer OUC-Fx11-5T of the fucoxanthine, the affinity and dissociation constant of the nucleic acid aptamer OUC-Fx11-5T and the fucoxanthine is determined to be 68.2 nM through an isothermal titer thermal method, the nucleic acid aptamer OUC-Fx11-5T has no obvious affinity to structural analogues of the fucoxanthine such as violaxanthin, neoxanthin, zeaxanthin and beta-carotene, has high affinity and good specificity to the fucoxanthine, and can be used for preparing the fucoxanthine aptamer OUC-Fx11-5T of the fucoxanthine. The method can be used for identification or detection of fucoxanthine.
Owner:OCEAN UNIV OF CHINA

Anti-trifloxystrobin monoclonal antibody and application thereof

The invention discloses an anti-trifloxystrobin monoclonal antibody and an application thereof. A light chain variable region of the anti-trifloxystrobin monoclonal antibody has an amino acid sequence as shown in SEQ ID No.1, and a heavy chain variable region of the anti-trifloxystrobin monoclonal antibody has an amino acid sequence as shown in SEQ ID No.2. The monoclonal antibody has good affinity to trifloxystrobin, the half inhibitory concentration (IC50) of the monoclonal antibody is 4.55 ng / mL, the detection limit (IC10) of the monoclonal antibody is 1.34 ng / mL, the linear range (IC20-IC80) of the monoclonal antibody is 2.11-9.83 ng / mL, the cross reaction rate of the monoclonal antibody to structural analogues such as enestroburin, picoxystrobin and metoxystrobin is smaller than 1%, and the monoclonal antibody is high in specificity and has the advantages of being good in thermal stability, high in organic solvent and acid-base tolerance and high in sensitivity. The method is suitable for detecting trifloxystrobin residues in different environments.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Hybridoma cell strain secreting mefos monoclonal antibody and application of hybridoma cell strain

The invention relates to a hybridoma cell strain capable of secreting a mefos monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of immunodetection. According to the invention, the hybridoma cell strain capable of secreting the fenofos monoclonal antibody is obtained through screening, the fenofos monoclonal antibody has high specificity and high sensitivity to the fenofos, IC50 to the fenofos is 0.231 ng / mL, and the fenofos monoclonal antibody has no cross reaction to structural analogues of the fenofos, such as triazophos, diazinon, phorate, acetyl phorate, methamidophos and the like; therefore, low-concentration isoprophos can be accurately detected.
Owner:JIANGNAN UNIV

Hybridoma cell strain secreting dextromethorphan monoclonal antibody and application thereof

The invention relates to a hybridoma cell strain capable of secreting dextromethorphan monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of immunodetection. The monoclonal antibody secreted by the hybridoma cell strain disclosed by the invention has good sensitivity and specificity on dextromethorphan, wherein the IC50 value on the dextromethorphan is 0.162 ng / mL. The monoclonal antibody provided by the invention has no cross reaction on structural analogues of dextromethorphan, such as fentanyl, thilazine, papaverine, morphine and medetomidine, and has good specificity, so that the dextromethorphan with low concentration can be accurately detected.
Owner:JIANGNAN UNIV

Hybridoma cell strain VAND8, vanillin-resistant monoclonal antibody generated by hybridoma cell strain VAND8 and application

The invention relates to a hybridoma cell strain VAND8, an anti-vanillin monoclonal antibody generated by the hybridoma cell strain VAND8 and application, and belongs to the field of immunochemistry. The hybridoma cell strain VAND8 provided by the invention can be used for preparing a high-titer vanillin-resistant monoclonal antibody, and the titer measured by an enzyme-linked immunosorbent assay (ELISA) method can reach 3.2 * 10 < 5 >; the vanillin-resistant monoclonal antibody provided by the invention is high in sensitivity and good in specificity, the 50% inhibition concentration IC50 on vanillin is 22.1 mu g / mL, and the cross reaction rate with vanillin structural analogues is low or even no cross reaction exists; the method can be used for measuring the content of vanillin.
Owner:OIL CROPS RES INST CHINESE ACAD OF AGRI SCI

Hybridoma cell strain secreting napropamide monoclonal antibody and application of hybridoma cell strain

The invention provides a hybridoma cell strain secreting a napropamide monoclonal antibody and application of the hybridoma cell strain, and relates to the technical field of immunodetection. The monoclonal antibody secreted by the hybridoma cell strain disclosed by the invention has good sensitivity to the napropamide, and the IC50 of the monoclonal antibody disclosed by the invention to the napropamide is 1.13 ng / mL, so that the monoclonal antibody disclosed by the invention can be used for detecting trace napropamide. In addition, the monoclonal antibody disclosed by the invention has no cross reaction on structural analogues of the napropamide, such as alachlor, acetochlor, propachlor, propanil, diquat and diuron, so that the monoclonal antibody disclosed by the invention can be used for accurately detecting the low-concentration napropamide.
Owner:JIANGNAN UNIV +1

Mass spectrometric detection method for enriching serum human insulin by using specific antibody immunomagnetic beads

The invention relates to the field of medical detection, in particular to a mass spectrometric detection method for enriching serum human insulin by using specific antibody immunomagnetic beads. According to the present invention, the human insulin in the serum is subjected to immune enrichment by using the magnetic beads coated with the insulin specific antibody, and the concentration level of the human insulin in the serum is accurately determined based on the accurate quantification technology of the isotope dilution liquid chromatography-tandem mass spectrometry platform in combination with the bracket method quantification mode. The pretreatment method provided by the invention is simple and convenient to operate, the absolute recovery rate is excellent, the sensitivity requirement is met, and the mass spectrometry method is an isotope diluent liquid chromatography-tandem mass spectrometry method capable of eliminating interference of structural analogues.
Owner:AUTOBIO DIAGNOSTICS CO LTD

Method and system for quantitatively detecting antibody drugs by using dimethyl-labeled modified peptide fragment as internal standard

The invention belongs to the technical field of biological drug analysis, and particularly relates to a method and a system for quantitatively detecting antibody drugs by using a dimethyl-labeled modified peptide fragment as an internal standard. Sequentially carrying out dimethyl labeling on the enzymolysis peptide fragments of the antibody drugs to obtain a plurality of dimethyl-labeled modified peptide fragments which are used as internal labels; the method comprises the following steps: enriching antibody drugs in a biological sample, and carrying out enzyme digestion to obtain a plurality of unlabeled modified peptide fragments; and mixing the unlabeled modified peptide fragment with an internal standard, enriching the modified peptide fragment, and then carrying out quantitative detection on the modified peptide fragment by adopting liquid chromatography-tandem mass spectrometry. A one-to-one structural analogue internal standard is provided for the modified peptide fragment, and the matrix effect is eliminated. Meanwhile, the method is combined with a high-pH reversed-phase grading equal peptide fragment enrichment method, so that the detection sensitivity of the modified peptide fragments in the matrix is improved. The technology provides a sensitive and reliable quantitative analysis method for the modified peptide fragment, and can be used for quantitative analysis of antibody drugs in biological samples.
Owner:HUAZHONG UNIV OF SCI & TECH

Olfactory receptor for bactrocera dorsalis to feel methyleugenol and application of olfactory receptor

ActiveCN119060164ATarget screening is stable and efficientRealize prevention and controlBiocideCell receptors/surface-antigens/surface-determinantsBiotechnologyGenomics
The invention belongs to the technical field of biology, and particularly discloses application of an odorant receptor BdorOR94b1 as a target in prevention and treatment of bactrocera dorsalis. By means of functional genomics, electrophysiology, behavioristics and traditional chemical ecology, the effect of methyleugenol in the mating behavior of bactrocera dorsalis and a key olfactory receptor for male insects to recognize methyleugenol are comprehensively analyzed. The key odorant receptor BdorOR94b1 of bactrocera dorsalis for recognizing methyleugenol is identified for the first time, and the genome coding region sequence and transcribed amino acid sequence information of the key odorant receptor BdorOR94b1 are obtained, so that an important basis is provided for subsequently screening more stable and efficient structural analogues by taking the gene as a target, and a basis is also provided for development of nucleic acid pesticides.
Owner:AGRICULTURAL GENOMICS INSTITUTE AT SHENZHEN CHINESE ACADEMY OF AGRICULTURAL SCIENCES (SHENZHEN BRANCH GUANGDONG LABORATORY FOR LINGNAN MODERN AGRICULTURE)

A decoquinate hapten, antigen, antibody and preparation and application thereof

The present invention discloses a decoquinate hapten, antigen, antibody and their preparation and application, and relates to a decoquinate hapten, antigen, antibody and their preparation and application for detecting decoquinate residues. The present invention prepares a decoquinate hapten and an artificial antigen with a structural formula as shown in formula (I) by using a highly water-soluble arm, and further prepares a specific antibody for detecting decoquinate, and the half inhibition concentration IC of decoquinate is 50 The value was 12.3 ng / mL, and the detection limit LOD (IC 10 ) was 3.41 ng / mL, and the linear range (IC 20 ~IC 80 ) was 7.4~20.9ng / mL, and the cross-reaction rates to common structural analogs were all lower than 10%, indicating that the antibody had good specificity for decoquinate and could effectively eliminate the interference of other structural analog drugs.
Owner:GUANGZHOU VOCATIONAL COLLEGE OF TECH & BUSINESS

A method for highly selective extraction of vanillin using an ionic liquid / salt / sulfonylated calix[4]arene aqueous two-phase system

The present invention discloses a method for highly selectively extracting vanillin using an ionic liquid / salt / sulfonylated calix[4]arene aqueous two-phase system. n The extract containing vanillin is added to the aqueous two-phase system of mim]Br / Na3C6H5O7 / SC[4], mixed, centrifuged to separate the two phases completely, and the upper phase is collected to obtain the extracted vanillin. n mim]Br / Na3C6H5O7 aqueous two-phase system increases the polarity difference between the two phases, promotes the formation of the two-phase system, improves the distribution coefficient of vanillin in the two-phase system, and can highly selectively extract vanillin from a variety of structural analogs. The method is simple and easy.
Owner:YANGZHOU UNIV

Application of 4-chloro-2, 5-dimethoxy-N-[(2-methoxyphenyl) methyl] phenylethylamine in preparation of drug for inhibiting drug addiction

The invention relates to the technical field of medicines, and particularly discloses an application of 4-chloro-2, 5-dimethoxy-N-[(2-methoxyphenyl) methyl] phenylethylamine (25C-NBOMe) in preparation of a medicine for inhibiting addiction, and a preparation method of the 4-chloro-2, 5-dimethoxy-N-[(2-methoxyphenyl) methyl] phenylethylamine (25C-NBOMe). As a selective 5-HT2A receptor agonist, the compound can regulate a neural circuit from the prefrontal cortex to the marginal system and indirectly influence dopamine release, so that active drug foraging, relapse and preference behaviors of addicted individuals are inhibited. The invention further covers pharmaceutical salt forms and structural analogues of the compound and application of the compound in pharmaceutical compositions, and administration can be achieved through multiple dosage forms such as sustained-release implants and nasal spray. Compared with the existing drug for treating addiction, the invention has the advantages of independence, definite target spot, obvious curative effect, high safety and the like, is suitable for intervention of various addiction substances, and provides a new strategy for prevention and treatment of addiction behaviors.
Owner:NINGBO UNIV

Use of co-enzyme antagonists to slow metabolism

The invention relates to the use of at least one inhibitory structural analog or inhibitory functional analog of a coenzyme (such as thiamine for example) of an enzyme group, the enzyme members of which catalyze anabolic and / or catabolic and / or energy-releasing metabolic reactions that are of essential significance for the functionality of the overall metabolism of cells, in particular mammalian cells. The invention is used to treat patients in order to produce a general successive (in particular also continuous) slowing down of the metabolic processes of endogenous cells and exogenous cells in the body of the patient and thus achieve a slowing down of disease-causing processes in particular.
Owner:TAVARGENIX GMBH

Method for detecting tetrahydrocannabinol and hydride thereof by utilizing specificity of bridged beta-cyclodextrin and application of tetrahydrocannabinol and hydride thereof

The invention relates to a method for specifically detecting tetrahydrocannabinol and hydride thereof by utilizing bridged beta-cyclodextrin, and belongs to the technical field of analysis and detection of supramolecular materials. The method comprises the following steps: firstly, combining 1, 6-hexamethylenediamine bridged bis-beta-cyclodextrin with an indicator to form a supramolecular probe; in a buffer system with a pH value of 9-11, tetrahydrocannabinol or a hydride thereof specifically competes to be combined with a cavity and displaces an indicator by utilizing a synergistic inclusion effect of a bridging subject and dissociation difference of guest molecules, so that the system is subjected to fluorescence quenching or color change, and a structural analogue cannabidiol does not generate obvious interference. The method solves the problems that the sensitivity is low and cannabidiol cannot be effectively distinguished in the prior art through cooperation of specific main body construction and environment regulation, has the advantages of being rapid in detection, high in specificity, high in accuracy and the like, and is suitable for environment monitoring and field screening.
Owner:IND CROPS RES INST YUNNAN ACAD OF AGRI SCI

Diazo compounds with Anti-trypanosomal activities

The present invention provides diazo compounds having anti-trypanosomal activity, with less or no side-effects. The diazo compounds are structural analogue of quinapyramine and possess characteristics necessary for the targeted pharmacologic action of anti trypanosomosis, with reduced cytotoxicity. The compounds were found to have less cytotoxicity, and identical or better anti- parasitemia effect as compared to conventional quinapyramine sulfate.
Owner:INDIAN COUNCIL OF AGRI RES

Preparation and application of a hybridoma cell strain and its secreted uniform monoclonal antibody recognizing tylosin / tilmicosin

This invention belongs to the field of immunology and discloses a hybridoma cell line and the preparation and application of its secreted monoclonal antibody that uniformly recognizes tylosin / tilmicosin. The monoclonal antibody hybridoma cell line is named DES-AOAA-14D5, with accession number CGMCC NO: 45303. This invention utilizes decarboxymethyl tylosin and oxycarboxymethyl hydroxylamine to synthesize a hapten, conjugates a carrier protein to prepare a complete antigen, immunizes mice, and, through cell fusion and screening techniques, prepares a hybridoma cell line that can secrete a monoclonal antibody that uniformly recognizes tylosin / tilmicosin. IC50 50 The effective concentrations were 1.59 and 1.72 ng / mL, respectively, with a cross-reactivity rate as high as 92.44%. An immunoassay method for the simultaneous and accurate detection of tylosin / tilmicosin in milk was established using this antibody. The cut-off value for both tylosin and tilmicosin was 16 ng / mL, and no cross-reactivity was observed with other structural analogs. The detection method of this invention shows promising application prospects.
Owner:HENAN AGRICULTURAL UNIVERSITY

Automatic identification method for new pollutants and structural analogues thereof in environment complex sample

The invention discloses a method for automatically identifying new pollutants and structural analogues thereof in environment complex samples, which comprises the following steps of: firstly, analyzing co-occurrence of abundance of substances among samples by using a Pearson's correlation coefficient, and introducing program blank deduction and IQR-Fisher Z transformation abnormal value processing to improve reliability; then, a molecular network is constructed based on high correlation and spectrogram similarity, and cracking products in the source are filtered. Key points are as follows: an iterative annotation strategy is adopted: a candidate structure is obtained from a PubChem database according to m / z of a substance to be annotated, preliminary screening is performed by calculating a Tanimoto coefficient of a Morga fingerprint, or advanced annotation is performed in combination with predicted MS / MS spectrogram fragment matching of a Top-k candidate, and the substance which is successfully annotated is taken as a new round of seed compound, so that automatic recursive expansion of an annotation range is realized. According to the method, the dependence of a traditional method on a standard spectrogram is effectively overcome, and efficient and automatic identification of pollutants with novel structures and analogues thereof is realized.
Owner:SHANGHAI JIAOTONG UNIV

Composition, in particular cosmetic formulation, comprising a verbascoside extract

A composition, in particular a cosmetic formulation, comprising an extract containing verbascoside and / or derivatives thereof and / or structural analogs thereof, wherein the extract is prepared from aerial parts of plants selected from the group consisting of sesame plant (Sesamum indicum), Lippia citriodora, Haeberlea rhodopensis, Cistanche tubulosa, Syringa vulgaris, Aiuga reptens, Buddleija davidii, Verbena officinalis, and Olea europea or wherein the extract is prepared from cell callus cultures of said parts of plants.
Owner:MEDENA AG

Application of zinc oxide quantum dot fluorescent sensor and detection of kaempferol

The application belongs to the technical field of chemical analysis and detection, and discloses a zinc oxide quantum dot fluorescent sensor and application of the zinc oxide quantum dot fluorescent sensor in detection of kaempferol. The zinc oxide quantum dot fluorescent sensor is prepared by stirring zinc salt solution and lye uniformly, then adding amino silane and water to carry out sol-gel reaction to prepare a ZnO-QDs fluorescent probe solution; then, a substrate is immersed in the ZnO-QDs fluorescent probe solution to carry out incubation, and drying is carried out to obtain the zinc oxide quantum dot fluorescent sensor. S The zinc oxide quantum dot fluorescent sensor is applied to detection of kaempferol, can produce specific response with kaempferol, makes the fluorescence intensity of the ZnO-QD fluorescent probe gradually increase with the increase of the concentration of kaempferol, and can effectively exclude the interference of structural analogs such as quercetin and luteolin, so that the kaempferol in the sample can be accurately quantified; and the detection cost is low, the operation is convenient, the detection efficiency is high, the detection is green and safe, and the zinc oxide quantum dot fluorescent sensor is suitable for popularization and application.
Owner:SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES

Polypeptide coupling medicine as well as preparation method and application thereof

The invention discloses a polypeptide coupling drug and a preparation method and application thereof, and belongs to the technical field of biological medicine, the polypeptide coupling drug is formed by bonding and connecting cyclic peptide molecules, connecting arms, spacers and antibiotic drugs through chemical bonds; aIP-III D4A amide and structural analogues of AIP-III D4A amide are selected as cyclic peptide molecules; the connecting arm selects a molecule which is sensitive to the specificity of cathepsin B in lysosome; and the spacer is a structural fragment capable of being automatically degraded. The polypeptide coupling drug has a good antibacterial effect, especially has an outstanding treatment effect on intracellular bacterial infection which is relatively difficult in current clinical treatment, and can be used for preparing efficient antibacterial drugs.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Fucoidin nucleic acid aptamer OUC-Fx11-5T and application thereof

The application discloses a nucleic acid aptamer OUC-Fx11-5T of fucoxanthin and application thereof, and belongs to the technical field of nucleic acid aptamer. The nucleic acid aptamer OUC-Fx11-5T of fucoxanthin has a nucleotide sequence as shown in SEQ ID NO. 19. The nucleic acid aptamer OUC-Fx11-5T of fucoxanthin is applied to the recognition or detection of fucoxanthin. The nucleic acid aptamer OUC-Fx11-5T of fucoxanthin has an affinity dissociation constant of 68.2 nM with fucoxanthin by isothermal titration calorimetry, has no obvious affinity to structural analogs of fucoxanthin such as violaxanthin, neoxanthin, zeaxanthin and beta-carotene, has high affinity and good specificity to fucoxanthin, and can be used for the recognition or detection of fucoxanthin.
Owner:OCEAN UNIV OF CHINA

Hybridoma cell strain secreting mepiquat chloride monoclonal antibody and application of hybridoma cell strain

PendingCN121022759AImmunoglobulinsTissue cultureUniconazoleImmuno detection
The invention relates to a hybridoma cell strain secreting a mepiquat chloride monoclonal antibody and application of the hybridoma cell strain, and belongs to the technical field of immunodetection. The hybridoma cell strain is preserved in China General Microbiological Culture Collection Center (CGMCC) on April 17, 2025, the preservation address is No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC No.46517. The monoclonal antibody secreted by the hybridoma cell strain has good sensitivity and specificity to mepiquat chloride, the IC50 value of the mepiquat chloride is 4.981 ng / mL, structural analogues and functional analogues of the mepiquat chloride, such as chlormequat chloride, paclobutrazol and uniconazole, have no cross reaction, the cross reaction rate is smaller than 1%, and the monoclonal antibody secreted by the hybridoma cell strain can be used for preparing the mepiquat chloride monoclonal antibody. Therefore, low-concentration mepiquat chloride can be accurately detected.
Owner:JIANGNAN UNIV

A monoclonal antibody against trifloxystrobin and application thereof

The application discloses an anti-cyprodinil monoclonal antibody and application thereof. The light chain variable region of the anti-cyprodinil monoclonal antibody has an amino acid sequence shown in SEQ ID No. 1, and the heavy chain variable region has an amino acid sequence shown in SEQ ID No. 2. The monoclonal antibody has good affinity to cyprodinil, the half-inhibitory concentration (IC 50 ) is 4.55 ng / mL, the detection limit (IC 10 ) is 1.34 ng / mL, the linear range (IC 20 ~ IC 80 ) is 2.11~9.83 ng / mL, the cross-reaction rate of structural analogs such as fenamidone, bifenox and pheonox is less than 1%, the monoclonal antibody has the characteristics of good thermal stability, strong resistance to organic solvents and acid and alkali, high sensitivity, and is suitable for detecting cyprodinil residues in different environments.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Biomarker-guided multi-pathway longevity and neuroregeneration platform utilizing tryptamine-based compounds and coordinated aging pathway modulation

A platform extends lifespan and promotes neuroregeneration by administering a tryptamine-based compound, selected from psilocin, psilocybin, and a non-hallucinogenic structural analog of psilocin, together with coordinated modulators of aging pathways. A multi-parameter biomarker dataset spanning cellular senescence, mitochondrial function, inflammation, oxidative stress, genomic stability, telomere maintenance, epigenetic aging, and neuroplasticity is processed by a computational personalization engine to generate a pathway-dominance profile ranking each category by deviation from a reference distribution. The profile selects a personalized protocol pairing the tryptamine-based compound, which upregulates sirtuin 1, with modulators chosen for the dominant pathways. A closed-loop system measures longitudinal biomarkers, compares observed against predicted trajectories, and adjusts composition and dosing when a deviation exceeds a defined threshold. Compositions, methods of treatment, manufacturing methods, and kits are provided.
Owner:VARGAS ABRAHAM

Preparation method and application of 2-phenyl-2H-chromene compound

The invention belongs to the technical field of organic synthesis, and particularly relates to a preparation method and application of a 2-phenyl-2H-chromene compound. According to the method, benzaldehyde and o-hydroxyacetophenone are taken as initial raw materials, Claisen-Schmidt condensation is carried out under an alkaline condition to prepare 2-hydroxychalcone, NaBH4 is utilized to reduce carbonyl to prepare an intermediate 2-(1-hydroxy-3-phenyl allyl) phenol, and then in an alkaline environment created by organic alkali Et3N, a 2-phenyl-2H-chromene skeleton is constructed by utilizing the complexing effect of BTC for the first time. According to the synthesis route, the synthesis efficiency of the chromene is remarkably improved, a practical method is provided for rapidly constructing a 2-phenyl-2H-chromene skeleton, and an important foundation is laid for efficient synthesis and structure-function relationship research of the chromene and structural analogues thereof.
Owner:DALI UNIV

Conformation-locked amphibian skin peptide derivative and conjugate as well as preparation method and application of amphibian skin peptide derivative and conjugate

The invention provides a conformation-locked amphibian skin peptide derivative or a pharmaceutically acceptable salt thereof. The conformation-locked amphibian skin peptide derivative or the pharmaceutically acceptable salt thereof has a structural formula shown in the specification or a structural analogue thereof, x is derived from one amino acid in TLa, the sequence of the TLa is LLRHVVKILEKYL, and (X) 3 is composed of any continuous sequences in three TLa. The invention also provides a preparation method of the tumor microenvironment response type TLa derivative-STING agonist MSA-2 conjugate and an application of the tumor microenvironment response type TLa derivative-STING agonist MSA-2 conjugate in tumor immunotherapy. In-vivo experiments show that the conjugate can effectively inhibit primary tumor growth and distal pulmonary metastasis in a melanoma model, and tumors of part of mice can completely fade away. The conjugate disclosed by the invention is expected to be developed into a novel efficient and low-toxicity tumor immunotherapy drug.
Owner:SHANGHAI UNIV OF T C M

Application of bangia fusco-purpurea coumarin compound or structural analogue of bangia fusco-purpurea coumarin compound in preparation of anti-brain cancer drugs or reagents

The invention relates to application of a bangia coumarin compound or a structural analogue of the bangia coumarin compound in preparation of an anti-brain cancer drug or reagent. The bangia coumarin compound is hesperel enol which is a bangia coumarin compound. And the structural analogue of the coumarin compound is a structural analogue hesperelactone hydrate of the coumarin compound hesperelactone of bangia fusco-purpurea. The compound can reduce the survival rate of brain cancer cells, reduce invasion of the brain cancer cells and inhibit the characteristics of brain cancer tumor stem cells, so that the compound can be used for preparing drugs or reagents for treating brain cancer. Meanwhile, the lowest concentration of the hesperidin hydrate for inhibiting the tumor stem cell characteristics of brain cancer is the same as that of a clinical medicine temozolomide, and the lowest concentration of the hesperenol is lower than that of the temozolomide. In addition, the anti-brain cancer effect of the nerolidinol further comprises the effect of inhibiting a brain cancer tumor stem cell marker.
Owner:JIMEI UNIV

Purification method of beta-carotene fermentation liquor

The invention belongs to the technical field of beta-carotene treatment, and discloses a purification method of beta-carotene fermentation broth, which comprises the following steps: S1, pretreatment: adding a composite antioxidant with the mass percentage of 0.01%-0.1% into the fermentation broth, and then removing thalli and large-particle impurities through centrifugation or microfiltration; and S2, carrying out supercritical CO2 extraction. By integrating supercritical CO2 extraction, molecular imprinting adsorption, multi-stage membrane separation, programmed cooling crystallization and other technologies, the method has the following remarkable advantages that on one hand, efficient separation and purification are achieved, the selective separation efficiency of beta-carotene is remarkably improved through the synergistic effect of the supercritical CO2 extraction and molecular imprinting technologies, and the separation efficiency of beta-carotene is greatly improved; the impurities of structural analogues such as carotenoid in the fermentation liquor are effectively removed; on the other hand, the impurities with different molecular weights are accurately removed through the graded purification effect of the multi-stage membrane separation system, and the product purity is greatly improved.
Owner:WUXUE GRAMMER BIOTECHNOLOGY CO LTD